SH

SHINIL PHARMACEUTICAL CO., LTD.

012790 | KO

Overview

Corporate Details

ISIN(s):
KR7012790002
LEI:
Country:
South Korea
Address:
충북 충주시 앙성면 본평리 산 5-1, 충주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 841.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 876.9 KB
2025-03-24 00:00
AGM Information
정기주주총회결과
Korean 22.2 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 17.2 KB
2025-03-14 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.0 MB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.8 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 87.0 KB
2025-03-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 9.3 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-12-16 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 740.8 KB
2024-08-09 00:00
Interim / Quarterly Report
반기보고서 (2024.06)
Korean 738.9 KB
2024-06-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.9 KB
2024-05-16 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 788.8 KB

Automate Your Workflow. Get a real-time feed of all SHINIL PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SHINIL PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SHINIL PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America
INO
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America
INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America
TIL
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel
INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden
IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea
048530
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America
IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America
IVVD

Talk to a Data Expert

Have a question? We'll get back to you promptly.